Stay updated on SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Locations are reorganized under a new consolidated 'Locations' section, adding Ontario and Quebec sites and removing the previous separate state/location blocks.
    Difference
    1%
    Check dated 2025-12-17T22:41:56.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    Only the revision tag changed from v3.2.0 to v3.3.2; no core content appears to have changed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-25T11:41:34.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A government funding/operating-status notice was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-18T07:14:00.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    No substantive updates to the study details were observed; differences appear limited to formatting or visual layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:17:39.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Updated version to v3.2.0 and added a government operating-status notice; removed the previous v3.1.0 reference.
    Difference
    3%
    Check dated 2025-10-06T05:56:15.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Page updated to v3.1.0; removed the Ovarian cancer resource and old v3.0.2 reference.
    Difference
    0.3%
    Check dated 2025-09-29T03:13:11.000Z thumbnail image

Stay in the know with updates to SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SubQ Risankizumab vs Oral Apremilast in Psoriasis Clinical Trial page.